Why is Bharat Immunolog falling/rising?

As of 31-Oct, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 20.28, which reflects a decrease of 0.31 or 1.51%. The stock has underperformed its sector by 1.06% today and has been on a downward trend for the last two days, resulting in a total drop of 3.57% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 2.31%, and it has seen a significant decline of 14.75% year-to-date, compared to a positive return of 7.42% for the benchmark Sensex. Notably, there has been a rise in investor participation, with delivery volume increasing by 141.98% against the 5-day average, suggesting some interest despite the overall negative performance.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 3.65% over the past month and 7.42% year-to-date. This stark difference highlights the challenges faced by Bharat Immunolog, as it has consistently underperformed relative to the market over various time frames, including a 16.65% decline over the past year compared to the Sensex's 5.73% gain. The lack of available positive factors further compounds the stock's struggles, as there are no indications of favorable developments that might support a rebound in its price.